Comparative Bioavailability of Midazolam 7.5 mg/1.5 mL Oromucosal Solution (Buccolam®) Versus 10 mg/2 mL Solution for Injection (Hypnovel®) in Healthy Subjects.

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-504903-10-00

Acronym

LESVIBUCCO/23/BQ-3

Enrollment

Registered

2023-06-22

Start date

2023-08-16

Completion date

2023-09-22

Last updated

2023-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

No medical condition.

None listed

Sex/Gender

All

Age

18 Years to No maximum

Portugal

None listed

Source: EU CTIS · Data processed: Feb 4, 2026